TrialMolecular therapy : the journal of the American Society of Gene Therapy2012

Targeting CD20 in melanoma patients at high risk of disease recurrence.

Alice Pinc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.